Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NABOGO: Antibiotics for Uncomplicated Anogenital Gonorrhoea
NCT03294395Phase 3Completed
- Sponsor
- Public Health Service of Amsterdam
- Start
- Sep 2017
- Primary completion
- Jun 2020
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ertapenem, gentamicin and fosfomycin in gonorrhea, sponsored by Public Health Service of Amsterdam. Started Sep 2017; status: completed.
02
Drugs
ertapenemgentamicinfosfomycin
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT03294395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03294395.